Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2002-10-23

• Fields of study

  Medicine

• Identifiers
  PMID 12387654
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence.

  2004cited by this paper
• MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.

  2002cited by this paper
• Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study.

  2001cited by this paper
• Underestimation of the Importance of Homocysteine as a Risk Factor for Cardiovascular Disease in Epidemiological Studies

  2001cited by this paper
• Is hyperhomocysteinemia a risk factor or a consequence of coronary heart disease?

  2001cited by this paper
• Hyperhomocystinemia: a risk factor or a consequence of coronary heart disease?

  2001cited by this paper
• Epidemiological methods for studying genes and environmental factors in complex diseases.

  2001cited by this paper
• Plasma total homocysteine concentration and the risk of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Studytpdel

  2000cited by this paper
• Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men.

  2000cited by this paper
• Cerebral white matter lesions and cognitive function: The Rotterdam scan study

  2000cited by this paper
• Homocysteine and cardiovascular disease: cause or effect?

  2000cited by this paper
• Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study.

  1999cited by this paper
• Nonfasting Plasma Total Homocysteine Level and Mortality in Middle-Aged and Elderly Men and Women in Jerusalem

  1999cited by this paper
• Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies.

  1999cited by this paper
• Homocysteine and risk of cardiovascular disease among postmenopausal women.

  1999cited by this paper
• Serum total homocysteine and coronary heart disease: prospective study in middle aged men

  1999cited by this paper
• Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women.

  1999cited by this paper
• Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria.

  1999cited by this paper
• Plasma homocysteine levels in patients with coronary heart disease.

  1998cited by this paper
• Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up.

  1998cited by this paper
• Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study.

  1998cited by this paper
• Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

  1998cited by this paper
• Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.

  1998cited by this paper
• Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials

  1998cited by this paper
• The Diagnostic Value of Serum Homocysteine Concentration as a Risk Factor for Coronary Artery Disease

  1998cited by this paper
• Homocysteine and ischaemic heart disease in the Caerphilly cohort.

  1998cited by this paper
• Homocysteine Levels and Coronary Heart Disease in Syria

  1998cited by this paper
• Plasma homocysteine levels in patients with coronary heart disease.

  1998cited by this paper
• Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene.

  1997cited by this paper
• Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial.

  1997influential reference
• Gender differences and other determinants of the rise in plasma homocysteine after L-methionine loading.

  1997cited by this paper
• Plasma homocysteine levels and mortality in patients with coronary artery disease.

  1997cited by this paper
• Features, symptoms, and neurophysiological findings in stroke associated with hyperhomocysteinemia.

  1997cited by this paper
• Mild Hyperhomocysteinemia and Hemostatic Factors in Patients with Arterial Vascular Diseases

  1997cited by this paper
• Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study.

  1997cited by this paper
• Association between hyperhomocysteinemia and ischemic heart disease in Sri Lankans.

  1997cited by this paper
• Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

  1997cited by this paper
• Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis.

  1997cited by this paper
• Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease.

  1997cited by this paper
• Low whole-blood S-adenosylmethionine and correlation between 5-methyltetrahydrofolate and homocysteine in coronary artery disease.

  1996cited by this paper
• Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate.

  1996cited by this paper
• Plasma homocyst(e)ine levels and graded risk for myocardial infarction: findings in two populations at contrasting risk for coronary heart disease.

  1996cited by this paper
• Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus.

  1996cited by this paper
• Hyperhomocysteinaemia and premature coronary artery disease in the Chinese.

  1996cited by this paper
• [Hyperhomocysteinemia in coronary artery diseases. Apropos of a study on 102 patients].

  1996cited by this paper
• Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

  1995cited by this paper
• Plasma homocysteine in acute myocardial infarction: homocysteine‐lowering effect of folic acid

  1995cited by this paper
• Higher plasma homocyst(e)ine and increased susceptibility to adverse effects of low folate in early familial coronary artery disease.

  1995cited by this paper
• Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate, and folate.

  1995cited by this paper
• Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis.

  1995cited by this paper
• Serum total homocysteine and coronary heart disease.

  1995cited by this paper
• A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

  1995cited by this paper
• Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease.

  1995cited by this paper
• Plasma homocysteine in the acute and convalescent phases after stroke.

  1995cited by this paper
• A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

  1995cited by this paper
• Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men.

  1994cited by this paper
• Disordered methionine/homocysteine metabolism in premature vascular disease: Dudman NPB, Wilcken DEL, Wang J, Lynch JF, Macey D, Lundberg P. Arterioscler Thromb 1993;13:1253-60

  1994cited by this paper
• Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease.

  1994cited by this paper
• A Prospective Study of Plasma Homocyst(e)ine and Risk of Ischemic Stroke

  1994cited by this paper
• Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study.

  1994cited by this paper
• Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology.

  1993cited by this paper
• A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians.

  1992cited by this paper
• Hyperhomocysteinemia: an independent risk factor for vascular disease.

  1991cited by this paper
• Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group.

  1991cited by this paper
• Influence of hydrolysis on plasma homocysteine determination in healthy subjects and patients with myocardial infarction.

  1991cited by this paper
• Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.

  1990cited by this paper
• Plasma homocyst(e)ine levels in men with premature coronary artery disease.

  1990cited by this paper
• Homocysteine and myocardial infarction.

  1988cited by this paper
• Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease.

  1985cited by this paper
• Moderate Homocysteinemia - A Possible Risk Factor For Arteriosclerotic Cerebrovascular Disease

  1984cited by this paper
• Estrogen Replacement Therapy and Coronary Heart Disease

  1983cited by this paper
• The pathogenesis of coronary artery disease. A possible role for methionine metabolism.

  1976cited by this paper
• Pathogenesis of coronary artery disease

  1969cited by this paper
• Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.

  1969cited by this paper
• Pathogenesis of coronary artery disease.

  1960cited by this paper

• Recurrent venous thrombosis in an adolescent male with CBS mutation and persistent antiphospholipid antibody positivity: a case report

  2026cites this paper
• Vitamin Supplementation in Sports: A Decade of Evidence-Based Insights

  2026cites this paper
• Folic acid supplementation on congenital heart disease and its dual character

  2025cites this paper
• Arterial thickness measurements on high-resolution ultrasonography in diabetics with and without macrovascular complications and their relationship with homocysteine level

  2025cites this paper
• Impact of Alterations in Homocysteine, Asymmetric Dimethylarginine and Vitamins-Related Pathways in Some Neurodegenerative Diseases: A Narrative Review

  2025cites this paper
• Poor clinical outcome despite successful recanalisation in patients with acute myocardial infarction undergoing direct percutaneous coronary intervention: a retrospective cohort study

  2025cites this paper
• Comparison of two measurement error-correction approaches for assessing the association between choline intake and coronary heart disease prevalence among US community-dwelling adults.

  2025cites this paper
• Blood Levels of Homocysteine Predict Cardiovascular Events, but not Alzheimer Disease Dementia, During a 4.7-year Follow-up in Patients with Vascular Risk Factors.

  2025cites this paper
• Unveiling The Metabolic-Neurophysiological Interplay of Vitamin B₁₂ In Young Adults: A Systematic Review

  2025cites this paper
• Analysis of risk factors for non-cardioembolic (large-artery atherosclerotic) cerebral infarction with and without intracranial large vessel occlusion: focus on immune-related markers

  2025cites this paper
• Machine Learning-Enabled Time-Resolved Nanozyme-Encoded Recognition of Endogenous Mercaptans for Disease Diagnosis.

  2025cites this paper
• Homocysteine and Multiple Health Outcomes: An Outcome-Wide Umbrella Review of Meta-analyses and Mendelian Randomization Studies

  2025cites this paper
• Elevated Homocysteine: A Critical Risk Factor for Stroke Types and Subtypes - A Systematic Review and Meta-Analysis of 96 Studies.

  2025cites this paper
• RETRACTED ARTICLE: Protective effects of pyridoxine, amlodipine, and their combination in a vasopressin-induced angina model in rats

  2025cites this paper
• A sample-to-answer multimodal microfluidic integrated electrochemical biosensing system for rapid diagnosis of acute stroke from whole blood

  2025cites this paper
• Homocysteine: Canary in the Coal Mine or Hidden Threat? A Biochemical Study on the Role of Plasma Thiols

  2025cites this paper
• Differential Effects of Pre-Stroke Antithrombotic Medication on Clinical Outcomes of Patients with Hyperhomocysteinemia and First-Ever Stroke Versus Recurrent Stroke

  2025cites this paper
• Association of hyperhomocysteinemia and IVF Live Birth Rate: a Retrospective Cohort Study.

  2025cites this paper
• Cross-sectional study on the association between 24-hour urinary potassium excretion and the risk of H-type hypertension and non-H-type hypertension in Chinese adults

  2025cites this paper
• Association of plasma homocysteine with cardiovascular disease in American adults: a study based on the national health and nutrition examination survey database

  2025cites this paper
• Plasma Homocysteine Levels and Intracerebral Hemorrhage: A Mendelian Randomization Analysis

  2025cites this paper
• Differential impact of lipid levels on the association between homocysteine and new-onset atrial fibrillation in acute myocardial infarction patients

  2025cites this paper
• Sex difference in the association between metabolic syndrome and the risk of stroke: a systematic review and meta-analysis

  2025cites this paper
• Nicotinamide N-methyltransferase in cardiovascular Diseases: Mechanistic insights and therapeutic potential.

  2025cites this paper
• Methotrexate Enhances Atherosclerosis Progression via Impairment of Folate Pathway in a Microminipig Model

  2025cites this paper
• The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma.

  2025cites this paper
• The relationship between dietary vitamin B1 and stroke: a machine learning analysis of NHANES data

  2025cites this paper
• Role and Relationship Between Homocysteine and H2S in Ischemic Stroke

  2025cites this paper
• Arterial and Venous Thromboembolism Associated With Whippet-Induced Vitamin B12 Deficiency

  2025cites this paper
• Association of MTHFR and DNMT-1 Gene Polymorphisms with Acute Coronary Syndrome in Patients Admitted to the Emergency Department

  2025cites this paper
• Role of hyperhomocysteinemia in atherosclerosis: from bench to bedside

  2025cites this paper
• Pancreatitis Is an Emerging Rare Complication of Classic Homocystinuria: A Case Series and Literature Review

  2025cites this paper
• Ischemic stroke increases levels of the folate receptor and one-carbon enzymes in male and female brain tissue

  2025cites this paper
• Combined effect of hyperhomocysteinemia and mild-to-moderate chronic kidney disease on mortality and cardiovascular events in the Japanese general population: the Yamagata (Takahata) study

  2025cites this paper
• Therapeutic effects of low-intensity transcranial ultrasound on neurological recovery in rat models of MCAO with varying injury severities.

  2025cites this paper
• S‐Propargyl‐Cysteine Attenuates Stroke Heterogeneity via Promoting Protective Autophagy Across Multiple Neural Cell Types: Insights From Single‐Cell Sequencing

  2025cites this paper
• Study on the relationship between homocysteine and general metabolic indexes in healthy population in Hebei Province, China

  2025cites this paper
• Intervention at Circulating Homocysteine Levels >10 µmol/L for Primary Prevention of Cardiovascular Diseases: A Systematic Review and Dose–Response Meta‐Analysis

  2025cites this paper
• Steroids and One-Carbon Metabolism: Clinical Implications in Endocrine Disorders

  2025cites this paper
• Prevalence and Metabolic Characterization of Polycystic Ovary Syndrome in a Cohort of Patients Diagnosed with Spina Bifida: Study Protocol

  2025cites this paper
• Association of plasma homocysteine levels with the presence of intracranial aneurysms and the risk of rupture: A systematic review and meta-analysis.

  2025cites this paper
• Uncovering Hyperhomocysteinemia: Global Risk Patterns and Molecular Disruption in Brain and Vascular Health

  2025cites this paper
• Selected Biochemical, Hematological, and Immunological Blood Parameters for the Identification of Malnutrition in Polish Senile Inpatients: A Cross-Sectional Study

  2025cites this paper
• Anemia in diabetes mellitus: Pathogenetic aspects and the value of early erythropoietin therapy

  2025cites this paper
• Recent Advances in Stroke Genetics—Unraveling the Complexity of Cerebral Infarction: A Brief Review

  2025cites this paper
• Nutritional Evaluation of Therapeutic Diets for Cardiovascular Diseases in Hospitals of General Santos City, Philippines: A Comparative Cross-sectional Study

  2025cites this paper
• Prognostic Significance of Homocysteine Levels in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Propensity Score Matching and Weighting Analysis

  2025cites this paper
• Effect of hyperhomocysteinemia on the prognostic value of triglyceride glucose index in patients with acute coronary syndrome

  2025cites this paper
• Differential effects of synthetic estrogen on serum homocysteine levels before and after menopause

  2025cites this paper
• Dietary Riboflavin Intake and the Risk of Stroke: Insights From NHANES 2007–2018

  2025cites this paper
• Cerebral infarction in a teenager with persistent hyperhomocysteinemia

  2025cites this paper
• T-2 toxin induces cardiac fibrosis by causing metabolic disorders and up-regulating Sirt3/FoxO3α/MnSOD signaling pathway-mediated oxidative stress.

  2024cites this paper
• Homocysteine modifies the association of coronary stenosis and HIV infection in an inner city African American population

  2024cites this paper
• Preventing hyperhomocysteinemia using vitamin B6 supplementation in Givosiran-treated acute intermittent porphyria: Highlights from a case report and brief literature review

  2024cites this paper
• Homocysteine: A futile comeback or a promising tool for the risk assessment of hypertensive patients?

  2024cites this paper
• Intestinal mucosal barrier: a potential target for traditional Chinese medicine in the treatment of cardiovascular diseases

  2024cites this paper
• Associations of total homocysteine and kidney function with all-cause and cause-specific mortality in hypertensive patients: a mediation and joint analysis

  2024influential citation
• Prospective analysis of pre and postoperative laboratory parameters associated with thrombosis in patients with ovarian cancer

  2024cites this paper
• Evaluation of In Vivo Folic Acid Bioavailability in Different Mouse Strains Using Enzymatic Digestion Combined with Ultra Performance Liquid Chromatography.

  2024cites this paper
• Exploring clinical indicator variations in stroke patients with multiple risk factors: focus on hypertension and inflammatory reactions

  2024cites this paper
• Evaluation of cardiovascular risk marker in patients with polycystic ovary syndrome: Homocysteine

  2024cites this paper
• Cardiac manifestations in inherited metabolic diseases.

  2024cites this paper
• Values of H-Type Hypertension in Patients with Large Vessel Occlusion

  2024cites this paper
• Methionine synthetase A2756G and Cystathionine-β-synthase 844ins68 polymorphisms and coronary artery disease: a meta-analysis.

  2024cites this paper
• Burden of Vitamin D and Vitamin B12 Deficiency among Older Patients in North India: a Single-Centre Study.

  2024cites this paper
• Vegetable and Fruit Intake and LOX-Index in Japanese Municipal Workers.

  2024cites this paper
• Homocysteine Blood Levels and Mandatory Folic Acid Fortification in Serbia.

  2024cites this paper
• Association of variants in AGTR1, ACE, MTHFR genes with microalbuminuria and risk factors for the onset of diabetic nephropathy in adolescents with type 1 diabetes in the population of Serbia

  2024cites this paper
• Body fluid multiomics in 3PM-guided ischemic stroke management: health risk assessment, targeted protection against health-to-disease transition, and cost-effective personalized approach are envisaged

  2024cites this paper
• Association of plasma homocysteine with cardiometabolic multimorbidity: a cross-sectional study in northwest China

  2024cites this paper
• Association between serum homocysteine and erectile dysfunction: a systematic review and meta-analysis

  2024influential citation
• The Influence of the Cooperation of Hyperhomocysteinemia and Arterial Hypertension. A Risk Factor on the Acceleration of the Progress of Chronic Renal Diseases

  2024cites this paper
• Vitamin B6, B12, and Folate’s Influence on Neural Networks in the UK Biobank Cohort

  2024cites this paper
• Leukoaraiosis: Epidemiology, Imaging, Risk Factors, and Management of Age-Related Cerebral White Matter Hyperintensities

  2024cites this paper
• Machine learning-based nomogram: integrating MRI radiomics and clinical indicators for prognostic assessment in acute ischemic stroke

  2024cites this paper
• Cardiac Manifestations in Inherited Metabolic Diseases.

  2024cites this paper
• Effect of probiotic administration during pregnancy on the functional diversity of the gut microbiota in healthy pregnant women

  2024cites this paper
• Elevated homocysteine is negatively correlated with plasma cystathionine β‐synthase activity in givosiran‐treated patients

  2024cites this paper
• Dietary vitamin B6 intake and stroke are negatively associated in adults: A cross-sectional study from the NHANES

  2024cites this paper
• Choline consumption reduces CVD risk via body composition modification

  2024cites this paper
• Folate, Homocysteine, and Adverse Outcomes After Ischemic Stroke

  2024cites this paper
• The Multitarget Action of Vitamins in the Ischemic Stroke.

  2024cites this paper
• Is renal function the key to disease risk management in elevated homocysteine levels?

  2024cites this paper
• Causal Effect of Macronutrient and Micronutrient Intake on Stroke: A Two-Sample Mendelian Randomization Study

  2024cites this paper
• Hypertension may lead to cognitive dysfunction in older adults via methylmalonic acid: evidence from NHANES 2011–2014 population

  2024cites this paper
• Homocysteine serum levels in patients with ruptured and unruptured intracranial aneurysms: a case-control study

  2023cites this paper
• Association between nutritional status and gait performance in Alzheimer's disease

  2023cites this paper
• MTHFR and risk of stroke and heart disease in a low-folate population: a prospective study of 156 000 Chinese adults

  2023cites this paper
• Association Analysis of Gut Microbiota and Prognosis of Patients with Acute Ischemic Stroke in Basal Ganglia Region

  2023cites this paper
• Recreational use of nitrous oxide causes seizure, pneumothorax, pneumomediastinum, and pneumopericardium: nitrous oxide and its harm, a case report

  2023cites this paper
• Investigation into the vascular contributors to dementia and the associated treatments.

  2023cites this paper
• Shedding Light on Lysosomal Malondialdehyde Affecting Vitamin B12 Transport during Cerebral Ischemia/Reperfusion Injury.

  2023cites this paper
• Intakes of folate, vitamin B6, and vitamin B12 and cardiovascular disease risk: a national population-based cross-sectional study

  2023cites this paper
• Predisposition to atherosclerosis in children and adults with trisomy 21: biochemical and metabolomic studies

  2023cites this paper
• Quantitative profiling and diagnostic potential of one-carbon and central metabolism pools in MODY2 and T1DM

  2023cites this paper
• Diagnostic et prise en charge des effets toxiques du protoxyde d’azote utilisé à des fins récréatives

  2023cites this paper
• Non-Conventional Risk Factors: “Fact” or “Fake” in Cardiovascular Disease Prevention?

  2023cites this paper
• Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022

  2023cites this paper
• How Do Minerals, Vitamins, and Intestinal Microbiota Affect the Development and Progression of Heart Disease in Adult and Pediatric Patients?

  2023cites this paper
• Prevalence and predictors of low folate levels among stroke survivors in a country without mandatory folate food fortification: Analysis of a Ghanaian sample.

  2023cites this paper